NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study. Using a novel method to assess spending on ...

Researchers estimated a median direct research and development cost of $150 million compared to a mean of $369 million. Costs were higher after adjusting for earnings drug developers could have ...

Researchers estimated a median direct research and development cost of $150 million compared to a mean of $369 million. Costs were higher after adjusting for the earnings drug developers could ...

Researchers estimated a median direct research and development cost of $150 million compared to a mean of $369 million. Costs were higher after adjusting for earnings drug developers could have ...

The cost of Kadcyla can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Kadcyla. As with all ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

SEATTLE — Sen. Patty Murray held a press conference Thursday in light of a cap on prescription drug costs for some on Medicare going into effect. Out-of-pocket costs for prescription medications ...

You can find 1, 2 and 3-bedroom units as well as duplexes in Lacina. Here’s a look at the covered areas of apartments for sale in Lacina, Ghaf Woods Phase 2. 1-bed ...

Plus, news about Hookipa and Capri­cor Ther­a­peu­tics: Hutchmed di­vests 45% stake in Chi­nese com­pa­ny: Hutchmed will get about $608 mil­lion in … ...

Neu­ro­science drug de­vel­op­er Neumo­ra Ther­a­peu­tics re­leased high­ly an­tic­i­pat­ed re­sults from the first of three Phase 3 tri­als for its ex­per­i­men­tal ma­jor … ...